Greece: Neuraxpharm targets Southeast Europe with Brain Therapeutics acquisition

Dr Jörg-Thomas Dierks, CEO Neuraxpharm

Neuraxpharm Group, a European specialty pharmaceutical company focused on the central nervous system (CNS), has acquired Athens-headquartered Brain Therapeutics, a CNS-focused marketing and distribution company with commercialization experience of CNS products in Greece, Cyprus and the Balkan countries. Brain Therapeutics specializes in the in-licensing and commercialization of pharmaceutical products in the CNS therapy area to address the needs…

You must be a HMI Subscriber to view this content.

Subscribe Now »